There is “weak evidence” to support puberty blockers for children who identify as transgender, according to a four-year systematic review of transgender medical studies published on Tuesday.
Dr. Hilary Cass, a consultant in paediatric disability at St. Thomas’ Hospital in London, England, and formerly the president of the Royal College of Pediatrics and Child Health, conducted the review in response to a request from the National Health Service (NHS). Cass’ report determined that the current studies on the subject of “puberty suppression” showed little improvement in gender dysphoria in minors and also may push kids toward getting more extreme treatments.
Read the full story